K

Karolinska Development

28 employees

Karolinska Development is an investment firm focused on identifying medical innovation and supporting the creation and growth of companies.

Investor insights

Countries invested in

sweden1

Sectors invested in

Biotechnology15
Health Care11
Medical9
Pharmaceutical7
Biopharma5
Clinical Trials3
Orthobiologics3
Cranioplasty3
Bone regeneration3
Neurosurgery3
Medical devices3
Orthopaedic surgery3
Bonegraft3
Spine surgery3
Therapeutics2
DOR agonists1
Test and Measurement1
Neuroscience1
Developing novel biologics and delivery methods for the treatment of neurological disorders.1
Personal Health1

Funding rounds participated in

$4.6M sweet spot round size

Most of their 22 investments are in rounds between $1.6M and $7M

Investor type

Venture Capital

Basic info

Industry

investment management

Sectors

Biotechnology
Therapeutics
Medical

Date founded

2003

Investments made

U

Undisclosed raised $672K on March 29, 2023

Investors: Karolinska Development

O

OssDsign raised $6.2M on November 29, 2022

Investors: Lancelot Asset Management and Karolinska Development

H

Henlez raised $985K on October 24, 2022

Investors: Eir Ventures and Karolinska Development

P

Pretzel Therapeutics raised $73M on September 12, 2022

Investors: GU Ventures, Eir Ventures, The Invus Group, GV, Cambridge Enterprise, Cambridge Innovation Capital plc, ARCH Venture Partners, HealthCap and Karolinska Development

P

PharmNovo raised $6.9M on June 3, 2022

Investors: Sciety, Polynom Investment AB (publ), Almi Invest and Karolinska Development

U

Undisclosed raised $1.1M on May 12, 2022

Investors: Karolinska Development

A

AnaCardio raised $3.6M on February 3, 2022

Investors: Karolinska Development

A

AnaCardio raised undisclosed on June 17, 2021

Investors: Karolinska Development

A

Aprea raised $57M on November 30, 2018

Investors: Sectoral Asset Management, Redmile Group, HealthCap, Versant Ventures, 5AM Ventures and Karolinska Development

F

Forendo Pharma Ltd raised $4.6M on September 5, 2018

Investors: Novo Holdings, Vesalius Biocapital, M Ventures and Karolinska Development

FAQ